What is the ROE (Return on Equity) of Covetrus this year?
The ROE of Covetrus this year is 0 undefined.
Covetrus ROE 2025
Covetrus ROE
0
Ticker
CVET
ISIN
US22304C1009
WKN
A2PBX0
In 2025, Covetrus's return on equity (ROE) was 0, a 0% increase from the 0 ROE in the previous year.
Covetrus Aktienanalyse
What does Covetrus do?
Covetrus Inc is a global company specializing in providing services and products for veterinarians, animal clinics, and pet owners. It was formed in 2019 through a merger between the animal health divisions of Henry Schein and Vets First Choice. Covetrus traces its history back to 1856 when Henry Schein was founded as a small wholesale drug company. Over the years, the company expanded into new industries and markets. In the 2000s, Henry Schein began serving the animal health industry and established Vets First Choice in 2010 to offer a wider range of services and products to veterinarians and animal clinics. With the merger of Vets First Choice and Henry Schein's animal health division in 2019, Covetrus was created as a company with a broad spectrum of products and services for the animal health industry. Covetrus is headquartered in Portland, Maine, USA, and operates in over 25 countries. Its business model is based on providing services and products for veterinarians, animal clinics, and pet owners. The company is divided into several business segments, including diagnostics, pharmaceuticals, and consumables. In the diagnostics area, Covetrus offers a wide range of laboratory diagnostic services for veterinarians, including blood tests, imaging, fecal tests, and genetic tests. These test results help veterinarians diagnose and treat diseases in pets. In the pharmaceutical area, Covetrus offers veterinary medicines for various types of pets, including dogs, cats, and horses. These medicines are developed by leading pharmaceutical companies, and Covetrus provides veterinarians with a reliable supply chain for these products. The most recent business segment of Covetrus is the consumables area. Here, the company offers a wide range of products for veterinarians and animal clinics, including medical devices, surgical instruments, consumables for routine examinations, and more. In addition to these three main business segments, Covetrus also offers a variety of services, including practice management systems, training for veterinarians and animal clinics, financial services, and more. These services are designed to help veterinarians and animal clinics optimize their operations and improve their quality. The company has also developed a mobile application called 'Covetrus Connect' which provides veterinarians and animal clinics with an easier way to access products and services, place orders, and manage their operations. Overall, Covetrus is an innovative and rapidly growing company in the animal health industry. With a wide range of products and services tailored to the needs of veterinarians, animal clinics, and pet owners, the company is well-positioned to continue growing in this emerging market. Covetrus ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROE Details
Decoding Covetrus's Return on Equity (ROE)
Covetrus's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.
Year-to-Year Comparison
Analyzing Covetrus's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.
Impact on Investments
Covetrus's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.
Interpreting ROE Fluctuations
Changes in Covetrus’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.
Frequently Asked Questions about Covetrus stock
How has the Return on Equity (ROE) of Covetrus developed compared to the previous year?
The ROE of Covetrus has increased by 0% decreased compared to the previous year.
What impact does a high ROE (Return on Equity) have on investors of Covetrus?
A high ROE indicates that Covetrus generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.
What impact does a low ROE (Return on Equity) have on investors of Covetrus?
A low ROE can indicate that Covetrus is having difficulties monetizing its investments successfully and can be a negative signal for investors.
How does a change in the ROE (Return on Equity) of Covetrus affect the company?
A change in ROE (Return on Equity) of Covetrus can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.
How to calculate the ROE (Return on Equity) of Covetrus?
The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.
Which factors influence the ROE (Return on Equity) of Covetrus?
Some factors that can influence Covetrus's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.
What strategic measures can take to improve the ROE (Return on Equity)?
To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.
How much dividend does Covetrus pay?
Over the past 12 months, Covetrus paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Covetrus is expected to pay a dividend of 0 USD.
What is the dividend yield of Covetrus?
The current dividend yield of Covetrus is .
When does Covetrus pay dividends?
Covetrus pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Covetrus?
Covetrus paid dividends every year for the past 0 years.
What is the dividend of Covetrus?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Covetrus located?
Covetrus is assigned to the 'Health' sector.
Wann musste ich die Aktien von Covetrus kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Covetrus from 1/19/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 1/19/2025.
When did Covetrus pay the last dividend?
The last dividend was paid out on 1/19/2025.
What was the dividend of Covetrus in the year 2024?
In the year 2024, Covetrus distributed 0 USD as dividends.
In which currency does Covetrus pay out the dividend?
The dividends of Covetrus are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Covetrus
Our stock analysis for Covetrus Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Covetrus Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
